Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Predicted Effector Gene Aggregation, Standards and Unified Schema (PEGASUS): A Community Framework for Effector Gene Reporting.

bioRxiv : the preprint server for biology·2026
Same author

Integrative genomic characterization of the FADS1-2-3 mood disorder risk locus: implications for the role of polyunsaturated fatty acids.

Journal of affective disorders·2026
Same author

A Common <i>CD36</i> Variant and the Genetic Landscape of Dilated Cardiomyopathy in Individuals of African Ancestry.

medRxiv : the preprint server for health sciences·2026
Same author

When the system fails: Barriers to type 1 diabetes medication access and the emergent role of social media support.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Phenome-wide study on alcohol consumption provides genetic evidence for a causal association with multiple diseases and biomarkers.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same author

Disentangling the relationship between psychiatric disorders, cardiometabolic abnormalities, and antipsychotics: A systematic review of genomic studies.

Schizophrenia research·2026

相关实验视频

Updated: May 10, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.2K

基于免疫细胞的转录的门德尔随机化和同位化研究,针对1型糖尿病.

Julie Sklar1, David Stacey2,3, Grace Nickel4

  • 1Frank H. Netter MD School of Medicine, Quinnipiac University, North Haven, CT, USA.

BMC medicine
|November 27, 2025
PubMed
概括

这项研究确定了21个新基因,包括VSIR和P2RY12,作为预防1型糖尿病 (T1D) 的潜在目标. 这些发现为T1D预防提供了新的药物开发和重新利用机会.

关键词:
药物开发 药物开发遗传流行病学遗传流行病学门德尔的随机化文字转录学 (Transcriptomics) 是一个学科.第1类糖尿病患者.

更多相关视频

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.2K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.2K

相关实验视频

Last Updated: May 10, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.2K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.2K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.2K

科学领域:

  • 免疫学 免疫学 免疫学
  • 遗传学 是一个遗传学.
  • 药理学 药理学 是一个学科.

背景情况:

  • 1型糖尿病 (T1D) 是一种免疫媒介疾病,预防策略有限.
  • 确定新的治疗点对于预防T1D发病至关重要.

研究的目的:

  • 通过使用孟德尔的随机化和局部化来发现T1D预防的新治疗点.
  • 为了利用免疫细胞衍生的遗传仪器进行目标识别.

主要方法:

  • 利用来自14项转录学研究的遗传变异来研究免疫细胞中的基因表达.
  • 分析了一个大型T1D全基因组关联研究 (GWAS) 数据集 (18,942例,501,638对照).
  • 进行了全现象扫描与 colocalization (PheWAS-coloc) 评估新奇性和性.

主要成果:

  • 在GWAS中优先考虑了21个以前与T1D无关的新基因.
  • 确定VSIR (VISTA) 作为T1D的保护性,具有较高的遗传预测与降低风险相关.
  • 突出了P2RY12作为一种药物重定向的机会,并将其表达与爱斯坦-巴尔病毒抗体水平联系起来.

结论:

  • 这项研究为T1D药物开发提供了新的遗传点.
  • 研究结果表明,有可能重新利用现有药物,例如针对P2RY12的药物.
  • 为预防或延迟1型糖尿病的发病提供了新的途径.